Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease
- PMID: 1454205
- DOI: 10.1016/0304-3940(92)90355-b
Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease
Abstract
Reduced and oxidized glutathione concentrations in post-mortem brain tissue from the substantia nigra of control subjects and patients with neuropathologically confirmed Parkinson's disease were measured by a coulometric method using high-pressure liquid chromatography and electrochemical detection. Reduced glutathione concentrations were decreased in the substantia nigra of parkinsonian patients compared with controls. Differences in the concentration of oxidized glutathione and in the percentage of oxidized glutathione of the total glutathione were not observed between parkinsonian and control subjects. The finding that oxidized glutathione is not decreased in Parkinson's disease suggests that the decrease in reduced glutathione is not exclusively the consequence of neuronal loss in the substantia nigra but may indicate a state of oxidative stress.
Similar articles
-
Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease.J Neural Transm (Vienna). 1997;104(6-7):661-77. doi: 10.1007/BF01291884. J Neural Transm (Vienna). 1997. PMID: 9444566
-
Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.Ann Neurol. 1994 Sep;36(3):348-55. doi: 10.1002/ana.410360305. Ann Neurol. 1994. PMID: 8080242
-
Oxidative stress and Parkinson's disease.Ann N Y Acad Sci. 1996 Jun 15;786:217-23. doi: 10.1111/j.1749-6632.1996.tb39064.x. Ann N Y Acad Sci. 1996. PMID: 8687021
-
Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group.Ann Neurol. 1992;32 Suppl:S82-7. doi: 10.1002/ana.410320714. Ann Neurol. 1992. PMID: 1510385 Review.
-
What process causes nigral cell death in Parkinson's disease?Neurol Clin. 1992 May;10(2):387-403. Neurol Clin. 1992. PMID: 1584181 Review.
Cited by
-
Dysregulation of glutathione homeostasis in neurodegenerative diseases.Nutrients. 2012 Oct 9;4(10):1399-440. doi: 10.3390/nu4101399. Nutrients. 2012. PMID: 23201762 Free PMC article. Review.
-
Recent updates in redox regulation and free radical scavenging effects by herbal products in experimental models of Parkinson's disease.Molecules. 2012 Sep 26;17(10):11391-420. doi: 10.3390/molecules171011391. Molecules. 2012. PMID: 23014498 Free PMC article. Review.
-
Neurobehavioural deficits following postnatal iron overload: II Instrumental learning performance.Neurotox Res. 2003;5(1-2):77-94. doi: 10.1007/BF03033374. Neurotox Res. 2003. PMID: 14628858 No abstract available.
-
NRF2 activation restores disease related metabolic deficiencies in olfactory neurosphere-derived cells from patients with sporadic Parkinson's disease.PLoS One. 2011;6(7):e21907. doi: 10.1371/journal.pone.0021907. Epub 2011 Jul 1. PLoS One. 2011. PMID: 21747966 Free PMC article.
-
The high-affinity D2/D3 agonist D512 protects PC12 cells from 6-OHDA-induced apoptotic cell death and rescues dopaminergic neurons in the MPTP mouse model of Parkinson's disease.J Neurochem. 2014 Oct;131(1):74-85. doi: 10.1111/jnc.12767. Epub 2014 Jun 21. J Neurochem. 2014. PMID: 24848702 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical